Refine results

Molecule down arrow
Disease state down arrow
Phase down arrow
Status down arrow

Showing 11 results

BGB-43395-101

BGB-43395-101

BGB-43395 Solid tumors Phase 1 Recruiting
RATIONALE-309 | BGB-A317-309

RATIONALE-309 | BGB-A317-309

Tislelizumab NPC Phase 3 Completed
RATIONALE-301 | BGB-A317-301

RATIONALE-301 | BGB-A317-301

Tislelizumab HCC Phase 3 Completed
RATIONALE-312 | BGB-A317-312

RATIONALE-312 | BGB-A317-312

Tislelizumab ES-SCLC Phase 3 Completed
RATIONALE-315 | BGB-A317-315

RATIONALE-315 | BGB-A317-315

Tislelizumab NSCLC Phase 3 Active, not recruiting
RATIONALE-307 | BGB-A317-307

RATIONALE-307 | BGB-A317-307

Tislelizumab NSCLC Phase 3 Completed
RATIONALE-304 | BGB-A317-304

RATIONALE-304 | BGB-A317-304

Tislelizumab NSCLC Phase 3 Completed
RATIONALE-303 | BGB-A317-303

RATIONALE-303 | BGB-A317-303

Tislelizumab NSCLC Phase 3 Completed

You are now leaving the website

This link is provided for information purposes only. You’ll be leaving beonemedaffairs.com and accessing a third-party website over which [BeOne Medicines | GmbH] has no control or influence.

This link will take you to a third-party website outside of beonemedaffairs.com.

[BeOne Medicines | GmbH] has no control over this website and makes no representations regarding its content or availability in your location. [BeOne Medicines | GmbH] declines any responsibility for third-party information, data usage policies, or personal data processing.

By proceeding, you acknowledge that you are part of the intended audience of the third-party website and confirm your compliance with applicable laws.

Do you want to leave beonemedaffairs.com

You are now leaving the the website beonemedaffairs.com and entering another BeOne website with different terms of use. Information included on this website may not be specific to your country. Click Continue to proceed